Innovative Medicines Canada statement on proposed pharmacare legislation
Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An […]
Newsroom
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
PRESS RELEASES
WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda
23 FEBRUARY 2024, GENEVA – The meeting of global trade ministers at the World Trade Organization’s 13th Ministerial Conference in […]
IMC statement on the FDA’s decision to allow Florida to import drugs from Canada
Ottawa, January 5, 2024 – Innovative Medicines Canada (IMC) is deeply concerned with the U.S. Food and Drug Administration’s (FDA) […]
IN THE NEWS
A Critical Moment for Canada: Ensuring World-Leading Access to Innovative Medicines
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
The Role of Pharma on the Path to New Medicines: A Conversation with IMC by Lung Cancer Canada
Dr. Paul Wheatley-Price chats with IMC President & CEO, Dr. Bettina Hamelin in this episode, covering off what IMC does, the role of […]
Leading the way: Empowering women leaders in Canada’s pharma sector
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
statements
Sorry, no posts were found. Please check again later.
Patient Stories
Contact
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
Sponsorship Applications
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
JOIN MEDIA LIST
Be the first to get our news
Sign up to our newsletter to get our latest news and updates.
